白雲山(00874.HK)控股子公司增資擴股完成工商變更登記
格隆匯 12 月 31日丨白雲山(00874.HK)發佈公吿,公司控股子公司廣州醫藥股份有限公司(“醫藥公司”)於2020年10月12日至2020年12月4日期間,在廣州產權交易所公開掛牌徵集符合條件之投資者。根據廣州產權交易所公開掛牌的摘牌情況、綜合評議以及競爭性談判,醫藥公司增資擴股最終引入戰略投資者1家,為中央企業貧困地區產業投資基金股份有限公司(“扶貧產業投資基金”);引入普通投資者5家,分別為海南晨菲投資控股有限公司、成都匯新匯源投資有限公司、陝西韜雲尚信息科技有限公司、佛山市文堅商務有限公司、梅州市鎬烽醫藥信息有限公司。
此次醫藥公司增資擴股新增股本222,305,500股,其中戰略投資者以現金方式認購醫藥公司增發股份79,681,275股,普通投資者以其持有醫藥流通企業股權認購醫藥公司增發股份142,624,225股。此次醫藥公司增資擴股掛牌價格為2.51元/股,是經評估機構以收益法對醫藥公司截至資產評估基準日2019年12月31日的股東全部權益評估所得評估值為基礎計算確定。
醫藥公司已於2020年12月30日完成此次增資擴股的相關工商登記變更手續並領取了新《營業執照》。公司作為醫藥公司原股東不參與此次增資,增資擴股事項完成後,公司持有醫藥公司股權比例由80.00%調整為72.74%,仍然擁有對醫藥公司的實際控制權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.